(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 3.88% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.99%.
Icon's revenue in 2026 is $8,102,602,000.On average, 20 Wall Street analysts forecast ICLR's revenue for 2026 to be $622,257,085,868, with the lowest ICLR revenue forecast at $570,637,771,836, and the highest ICLR revenue forecast at $659,673,452,548. On average, 18 Wall Street analysts forecast ICLR's revenue for 2027 to be $648,143,102,816, with the lowest ICLR revenue forecast at $586,673,357,556, and the highest ICLR revenue forecast at $688,461,146,912.
In 2028, ICLR is forecast to generate $702,511,374,400 in revenue, with the lowest revenue forecast at $619,889,927,976 and the highest revenue forecast at $781,162,104,360.